Skip to main content

Cardiovascular Conditions and Disorders News (Page 18)

Adding Cardiovascular Biomarkers to Established Risk Factors Increases Risk Prediction

MONDAY, May 13, 2024 – The addition of cardiovascular biomarkers to established risk factors leads to a small improvement in risk prediction of cardiovascular disease, according to a study published...

A Cardiologist Answers Your Questions on New Weight-Loss Meds, Ozempic and Zepbound

MONDAY, Feb. 12, 2024 – Weight loss drugs like Ozempic and Zepbound can lead to better heart health for people struggling with excess weight or diabetes, a University of Michigan cardiologist says....

A Cardiologist Answers Your Questions on New Weight-Loss Meds, Ozempic and Zepbound

MONDAY, Feb. 12, 2024 – Weight loss drugs like Ozempic and Zepbound can lead to better heart health for people struggling with excess weight or diabetes, a University of Michigan cardiologist says....

FDA Approves Gadavist (gadobutrol) Contrast Agent for Use in Cardiac MR in Adult Patients with Known or Suspected Coronary Artery Disease

WHIPPANY, N.J., July 15, 2019 /PRNewswire/ – Bayer announced today the U.S. Food and Drug Administration (FDA) has approved Gadavist (gadobutrol) injection for use in cardiac magnetic resonance (MR)...

FDA Approves Entresto (sacubitril/valsartan) for Heart Failure

July 7, 2015 – The U.S. Food and Drug Administration today approved Entresto (sacubitril/valsartan) tablets for the treatment of heart failure. The drug has been shown to reduce the rate of...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

High Blood Pressure, Hypertension, High Cholesterol, Heart Failure, Congestive Heart Failure, Prevention of Thromboembolism in Atrial Fibrillation, Prevention of Cardiovascular Disease, Arrhythmia, Hypotension, Heart Disease